1 |
Platelet membrane glycoproteins and their ligands and risk of myocardial infarctionCroft, Stuart Anthony January 2001 (has links)
No description available.
|
2 |
Genomic medicine in primary care: Texas physicians' adoption of an innovationSuther, Sandra Gayle 30 September 2004 (has links)
New applications of genomic medicine stemming from the Human Genome Project are predicted to become routine components of primary care. Primary care physicians (PCPs) will increasingly become responsible for screening patients for inherited diseases, recommending genetic testing, and making referrals to genetic services. Clinical applications of genomic medicine will occur at a variable pace. Characteristics of an innovation such as genomic medicine are strong indicators of its potential for adoption. The purpose of this study is to assess whether (and to what extent) physicians' perceptions of genomic medicine as an innovation influence their likelihood of adopting this innovation into primary care. The study's sample consists of 400 primary care physicians in Texas and employs a survey design. Based on Rogers' Diffusion of Innovations Theory, the perceived characteristics of genomic medicine - Relative Advantage, Compatibility, Complexity, Trialability, and Observability - are the study's independent/predictor variables. Likelihood of PCPs Adopting Genomic Medicine is the dependent variable. The nature of the social system (private or group practice) is examined as a possible moderator variable. The study suggests that Texas PCPs who are likely to adopt genomic medicine strongly perceive its clinical uses (such as genetic testing for carrier status or susceptibility to common diseases, testing an embryo for genetic disorders before it is implanted, and supplementing a family history) to be highly advantageous. For half of the PCPs, genetic services such as genetic counseling and genetic testing are not compatible with current practice. Perceived complexity of the innovation is the strongest predictor of likelihood of PCPs adopting genomic medicine. Many PCPs find it difficult to stay updated on genomic medicine and locate genetic services. Although Texas PCPs feel genomic medicine can be gradually incorporated into primary care practice, most are not presently observing their colleagues adopting genomic medicine or assisting their patients to make decisions regarding genetic services.
Future efforts to advance the use of genomic medicine in primary care will require more emphasis on genetics in medical school curriculum and continuing education programs. Links with specialists trained in genetic counseling and health education will be essential to translate relevant information to patients and families.
|
3 |
Opportunities for Hospital Librarians in the Era of Genomic MedicineElliott, Kathy 24 February 2012 (has links)
This is a research paper submitted for LIBR220 (Medical and Health Sciences Librarianship), a graduate course in Library and Information Sciences at San Jose State University. / PURPOSE:
To evaluate ways in which hospital librarians can help clinicians keep up with the rapid growth of genetic information and incorporate it into patient care as we enter the era of genomic medicine.
SETTING:
Hospital medical libraries
DESCRIPTION:
The fast-growing new field of genomic medicine applies human genetic information to the understanding and treatment of disease. Historically, evidence-based healthcare has been informed by studies on large populations. Breakthroughs in genetic analysis technologies are presenting healthcare providers with new opportunities to diagnose and customize clinical treatment based on the genetic structure of individual patients. In the hospital setting, access to genomic medicine information resources, clinical guidelines, and continuing education will be critical in the near future. This research paper will explore resources and programs that hospital librarians can offer to clinicians, to serve their genomic medicine information needs and help them navigate through unfamiliar territory.
|
4 |
Attitudes toward and current status of disclosure of secondary findings from next-generation sequencing: a nation-wide survey of clinical genetics professionals in Japan / 次世代シークエンサーにおける二次的所見の開示に関する実態―遺伝医療専門家を対象とした全国調査より―Tsuchiya, Mio 25 January 2021 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(社会健康医学) / 甲第22889号 / 社医博第113号 / 新制||社医||11(附属図書館) / 京都大学大学院医学研究科社会健康医学系専攻 / (主査)教授 川上 浩司, 教授 松田 文彦, 教授 中島 貴子 / 学位規則第4条第1項該当 / Doctor of Public Health / Kyoto University / DFAM
|
5 |
Three Dimensional Structure and Human Genetic Variants of PMS1 Protein; Potential Medical Consequences Due to Inefficient DNA Mistmatch RepairFilm , Sydney T. 30 April 2019 (has links)
No description available.
|
Page generated in 0.0875 seconds